Live Quote · NASDAQBMRNHealthcare· Biotechnology

BioMarin Pharmaceutical Inc.

$58.99 2.02%(+$1.17)
TickerSpark Score
74/100
Solid
76
Valuation
70
Profitability
45
Growth
100
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMRN research report →

52-Week Range57% of range
Low
$49.26
Current
$58.99
High
$66.28
Company Overviewwww.biomarin.com

About the company

BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products.

CEO
Alexander Hardy
IPO
1999
Employees
3,040
HQ
San Rafael, CA, US

Price Chart

+3.18% · this period
$64.08$56.88$49.67Jul 02Dec 31Jul 02
Valuation
Market Cap
$11.40B
P/E
42.25
P/S
3.52
P/B
1.83
EV/EBITDA
22.01
Div Yield
0.00%
Profitability
Gross Margin
75.93%
Op Margin
13.55%
Net Margin
8.29%
ROE
4.41%
ROIC
3.92%
Growth & Income
Revenue
$3.22B · 12.87%
Net Income
$348.90M · -18.26%
EPS
$1.82 · -19.11%
Op Income
$533.48M
FCF YoY
52.49%
Performance & Tape
52W High
$66.28
52W Low
$49.26
50D MA
$54.72
200D MA
$55.74
Beta
0.24
Avg Volume
2.05M

Get TickerSpark's AI analysis on BMRN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 2, 26Countouriotis Athenaother7,490
Jun 2, 26Walbert Timothy Pother7,490
Jun 2, 26Ho Maykinother7,490
Jun 2, 26HOMBACH ROBERT J.other7,490
Jun 2, 26Enyedy Mark Jother7,490
Jun 2, 26Dere Willard Hother7,490
Jun 2, 26CLARK IAN Tother7,490
Jun 2, 26Bodem Barbara W.other7,490
Jun 2, 26ANDERSON ELIZABETH Mother7,490
May 20, 26Hubbard Cristinother2,318
Coverage · BMRN

Our BMRN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on BMRN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate BMRN report →
Internal Compare

Similar companies

Peers in the same neighborhood.